AI Terminal
Brockhaus Technologies AG
Regulatory Filings • Aug 27, 2020
712_rns_2020-08-27_6ff2312c-ebfd-4848-a3e5-e59e171abb45.html
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 27 August 2020 22:35
Brockhaus Capital Management AG: BCM subsidiary Palas announces patent filing for a measuring device for the immediate determintation of size and number of particles in exhaled air
Brockhaus Capital Management AG / Key word(s): Patent/Market launch
Brockhaus Capital Management AG: BCM subsidiary Palas announces patent filing for a measuring device for the immediate determintation of size and number of particles in exhaled air
27-Aug-2020 / 22:35 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
BCM subsidiary Palas announces patent filing for a measuring device for the immediate determintation of size and number of particles in exhaled air
Frankfurt/Main, August 27, 2020.
Brockhaus Capital Management AG (BKHT, ISIN: DE000A2GSU42, “ BCM “) announces that its subsidiary Palas GmbH Partikel- und Lasermeßtechnik (“ Palas “) informed BCM today that Palas filed a patent with the European Patent Office today for a measuring device for the immediate determination of size and number of particles concentration in exhaled air.
The universally applicable measuring device developed by Palas can immediately identify particles with high-resolution regarding size in the exhaled air and could thus help to detect virus infections in humans, such as COVID-19. The size and number of the particles serve as an indicator for a potential disease of the tested person.
This could especially contribute to the containment during the current COVID-19 pandemic. Due to the immense social and economic importance of the COVID-19 pandemic, BCM expects a great demand for the new measuring device. If this assumption materializes, it would have a corresponding positive effect on the sales and earnings performance of BCM.
The product launch is planned for September 2020. The patent is pending; a patent application is generally published 18 months from the filing date and only after this period, the holder is entitled to rights from the patent application.
Contact details
For investors:
Brockhaus Capital Management – Paul Göhring
Head of Investor Relations
Phone: +49 69 20 43 40 978
Mobile: +49 151 4616 0724
Fax: +49 69 20 43 40 971
E-Mail: [email protected]
For media:
USC – Iris C. Sistemich
Phone: +49 221 280 655 10
E-Mail: [email protected]
27-Aug-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Brockhaus Capital Management AG |
| Thurn-und-Taxis-Platz 6 | |
| 60313 Frankfurt am Main | |
| Germany | |
| Phone: | +49 (0)69 2043 409 0 |
| Fax: | +49 (0)69 2043 409 71 |
| E-mail: | [email protected] |
| Internet: | http://bcm-ag.com |
| ISIN: | DE000A2GSU42 |
| WKN: | A2GSU4 |
| Listed: | Regulated Market in Frankfurt (Prime Standard) |
| EQS News ID: | 1124457 |
| End of Announcement | DGAP News Service |